<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091311</url>
  </required_header>
  <id_info>
    <org_study_id>LT2420-PIV-CE-01/10</org_study_id>
    <secondary_id>N° RCB 2010-A00017-32</secondary_id>
    <nct_id>NCT01091311</nct_id>
  </id_info>
  <brief_title>Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases</brief_title>
  <acronym>ESPOIR</acronym>
  <official_title>Phase IV Multicentric Study, 30 Patients Suffering of Meibomian Glands Dysfunction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Thea</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Thea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands
      dysfunction .

      Its objective is to Collect information from patients and ophthalmologists specialized in
      ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.

      This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.

      Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two
      uses per day) and complete a questionnaire every two days during the first week and then once
      a week the next two weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Actual">30</enrollment>
  <condition>Eyelid Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blephasteam</intervention_name>
    <description>Eye lid warming goggles</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Signed and dated informed consent.

          -  Male or female up to 4 years old.

          -  Known and treated symptomatic Meibomian Gland Diseases, and/or Dry Eye related to MGDs
             stable since at least a month.

          -  Without any active pathology requiring a change in ocular treatments within the last
             month before inclusion.

          -  Best corrected far visual acuity (VA) &gt; 1/10
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Baudouin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frédéric Chiambaretta, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Clermont Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serge Doan, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Bichat</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HÃ´pital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.H.N.O des XV-XX</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat - Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>June 7, 2011</last_update_submitted>
  <last_update_submitted_qc>June 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2011</last_update_posted>
  <keyword>Meibomian Gland Dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eyelid Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

